CIK 0001831828
- Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812744449
- Phone
- +1 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-21 | Cheng Andrew Director | Grant or award · Stock Option (right to buy) | +17,084 | 17,084 | ||
| 2025-05-14 | Cheng Andrew Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 | ||
| 2024-05-15 | Cheng Andrew Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 | ||
| 2023-05-10 | Cheng Andrew Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-05-24 | Cheng Andrew Director | Grant or award · Stock Option (right to buy) | +9,925 | 9,925 | ||
| 2021-05-18 | Cheng Andrew Director | Conversion | +17,488 | 17,488 | ||
| 2021-05-18 | Cheng Andrew Director | Conversion · Series C Preferred Stock | −17,488 | 0 | ||
| 2021-05-13 | Cheng Andrew Director | Grant or award · Stock Option (right to buy) | +9,925 | 9,925 |
Page 1 of 1 · 8 trades